<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
    <channel>
        <title><![CDATA[cilgavimab Feed]]></title>
        <description><![CDATA[cilgavimab articles]]></description>
        <link>https://sps.devopsroom.com</link>
        <generator>stiripesurse.ro</generator>
        <lastBuildDate>Fri, 13 Nov 2026 15:13:11 GMT</lastBuildDate>
        <atom:link href="https://sps.devopsroom.com/tag/cilgavimab/feed" rel="self" type="application/xml"/>
        <pubDate>Fri, 13 Nov 2026 15:13:11 GMT</pubDate>
        <language><![CDATA[ro-RO]]></language>
                <item>
            <title><![CDATA[Evusheld de la AstraZeneca își păstrează acțiunea neutralizantă împotriva variantelor Omicron BA.4 și BA.5, conform unui nou studiu al Universității Oxford]]></title>
            <description><![CDATA[Evusheld de la AstraZeneca își păstrează acțiunea neutralizantă împotriva variantelor Omicron BA.4 și BA.5, conform unui nou studiu al Universității Oxford]]></description>
            <link>https://sps.devopsroom.com/evusheld-de-la-astrazeneca-isi-pastreaza-actiunea-neutralizanta-impotriva-variantelor-omicron-ba4-si-ba5-conform-unui-nou-studiu-al-universitatii-oxford_2403480.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/evusheld-de-la-astrazeneca-isi-pastreaza-actiunea-neutralizanta-impotriva-variantelor-omicron-ba4-si-ba5-conform-unui-nou-studiu-al-universitatii-oxford_2403480.html</guid>
                        <category><![CDATA[studiu]]></category>
                        <category><![CDATA[Universitatea din Oxford]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[COVID-19]]></category>
                        <category><![CDATA[AZD7442]]></category>
                        <category><![CDATA[Evusheld]]></category>
                        <category><![CDATA[Omicron]]></category>
                        <category><![CDATA[tixagevimab]]></category>
                        <category><![CDATA[cilgavimab]]></category>
                        <category><![CDATA[John L. Perez]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <dc:creator><![CDATA[Denisa Miron, Colaborator]]></dc:creator>
            <pubDate>Fri, 27 May 2022 14:41:54 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202204/1600x900/media-165055709777608300.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[Evusheld demonstrează protecție semnificativă împotriva formelor simptomatice de COVID-19 pentru o perioadă de minim 6 luni în cadrul studiului clinic de fază I]]></title>
            <description><![CDATA[Evusheld demonstrează protecție semnificativă împotriva formelor simptomatice de COVID-19 pentru o perioadă de minim 6 luni în cadrul studiului clinic de fază I]]></description>
            <link>https://sps.devopsroom.com/evusheld-demonstreaza-protectie-semnificativa-impotriva-formelor-simptomatice-de-covid-19-pentru-o-perioada-de-minim-6-luni-in-cadrul-studiului-clinic-de-faza-i_2384945.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/evusheld-demonstreaza-protectie-semnificativa-impotriva-formelor-simptomatice-de-covid-19-pentru-o-perioada-de-minim-6-luni-in-cadrul-studiului-clinic-de-faza-i_2384945.html</guid>
                        <category><![CDATA[New England Journal of Medicine]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[COVID-19]]></category>
                        <category><![CDATA[AZD7442]]></category>
                        <category><![CDATA[Evusheld]]></category>
                        <category><![CDATA[tixagevimab]]></category>
                        <category><![CDATA[cilgavimab]]></category>
                        <category><![CDATA[omicron BA.2]]></category>
                        <category><![CDATA[AstraZeneca Evusheld]]></category>
                        <category><![CDATA[Myron J. Levin]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <dc:creator><![CDATA[Denisa Miron, Colaborator]]></dc:creator>
            <pubDate>Mon, 16 May 2022 08:41:28 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202204/1600x900/media-165055709777608300.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[AstraZeneca anunță aprobarea în UE a combinației de anticorpi cu acțiune prelungită Evusheld pentru profilaxia pre-expunere a COVID-19]]></title>
            <description><![CDATA[AstraZeneca anunță aprobarea în UE a combinației de anticorpi cu acțiune prelungită Evusheld pentru profilaxia pre-expunere a COVID-19]]></description>
            <link>https://sps.devopsroom.com/astrazeneca-evusheld_2313910.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/astrazeneca-evusheld_2313910.html</guid>
                        <category><![CDATA[Bucuresti]]></category>
                        <category><![CDATA[studiu]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[anticorpi monoclonali]]></category>
                        <category><![CDATA[Evusheld]]></category>
                        <category><![CDATA[PROVENT]]></category>
                        <category><![CDATA[profilaxie]]></category>
                        <category><![CDATA[tixagevimab]]></category>
                        <category><![CDATA[cilgavimab]]></category>
                        <category><![CDATA[Radu Rășinar]]></category>
                        <category><![CDATA[actiune prelungita]]></category>
                        <category><![CDATA[BA.1.1 și BA.2 Omicron SARS-CoV-2]]></category>
                        <category><![CDATA[Prof. Asociat Dr. Dana Lucia Stănculeanu]]></category>
                        <category><![CDATA[Universitatea de Medicină și Farmacie  „Carol Davila”]]></category>
                        <category><![CDATA[AstraZeneca România]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <dc:creator><![CDATA[Denisa Miron, Colaborator]]></dc:creator>
            <pubDate>Mon, 28 Mar 2022 17:49:37 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202112/1600x900/media-163939669339114300.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[Agenţia Europeană a Medicamentului recomandă un tratament de la AstraZeneca pentru prevenirea COVID-19 la cei de peste 12 ani]]></title>
            <description><![CDATA[Agenţia Europeană a Medicamentului recomandă un tratament de la AstraZeneca pentru prevenirea COVID-19 la cei de peste 12 ani]]></description>
            <link>https://sps.devopsroom.com/agentia-europeana-a-medicamentului-recomanda-un-tratament-de-la-astrazeneca-pentru-prevenirea-covid_2308590.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/agentia-europeana-a-medicamentului-recomanda-un-tratament-de-la-astrazeneca-pentru-prevenirea-covid_2308590.html</guid>
                        <category><![CDATA[Agenția Europeană a Medicamentului]]></category>
                        <category><![CDATA[EMA]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[Spike]]></category>
                        <category><![CDATA[COVID-19]]></category>
                        <category><![CDATA[anticorpi de sinteză]]></category>
                        <category><![CDATA[Evusheld]]></category>
                        <category><![CDATA[tixagevimab]]></category>
                        <category><![CDATA[cilgavimab]]></category>
                        <category><![CDATA[AstraZeneca AB]]></category>
                        <category><![CDATA[Știrile Zilei]]></category>
                        <category><![CDATA[Externe]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <category><![CDATA[Instant Articles]]></category>
                        <category><![CDATA[Stiri TV]]></category>
                        <category><![CDATA[Blitz TV]]></category>
                        <category><![CDATA[Parteneri Articole]]></category>
                        <dc:creator><![CDATA[Redactia Stiripesurse.ro]]></dc:creator>
            <pubDate>Fri, 25 Mar 2022 01:00:01 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202203/1600x900/media-164815302126205100.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[Agenţia Europeană a Medicamentului recomandă autorizarea tratamentului preventiv de la AstraZeneca pentru persoanele peste 12 ani]]></title>
            <description><![CDATA[Agenţia Europeană a Medicamentului recomandă autorizarea tratamentului preventiv de la AstraZeneca pentru persoanele peste 12 ani]]></description>
            <link>https://sps.devopsroom.com/agentia-europeana-a-medicamentului-recomanda-autorizarea-tratamentului-preventiv-de-la-astrazeneca-pentru-persoanele-peste-12-ani_2308600.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/agentia-europeana-a-medicamentului-recomanda-autorizarea-tratamentului-preventiv-de-la-astrazeneca-pentru-persoanele-peste-12-ani_2308600.html</guid>
                        <category><![CDATA[virus]]></category>
                        <category><![CDATA[Agenția Europeană a Medicamentului]]></category>
                        <category><![CDATA[EMA]]></category>
                        <category><![CDATA[astrazeneca]]></category>
                        <category><![CDATA[anticorpi]]></category>
                        <category><![CDATA[Spike]]></category>
                        <category><![CDATA[coronavirus]]></category>
                        <category><![CDATA[COVID-19]]></category>
                        <category><![CDATA[Evusheld]]></category>
                        <category><![CDATA[varianta omicron]]></category>
                        <category><![CDATA[tixagevimab]]></category>
                        <category><![CDATA[cilgavimab]]></category>
                        <category><![CDATA[Externe]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <category><![CDATA[Instant Articles]]></category>
                        <category><![CDATA[Stiri TV]]></category>
                        <category><![CDATA[Blitz TV]]></category>
                        <category><![CDATA[Parteneri Articole]]></category>
                        <category><![CDATA[Tarom AirFi]]></category>
                        <dc:creator><![CDATA[Anca-Adriana Huza]]></dc:creator>
            <pubDate>Thu, 24 Mar 2022 20:16:26 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202009/1600x900/media-159975127725281500.webp" length="0" type="image/webp"/>
        </item>
                <item>
            <title><![CDATA[Evusheld de la AstraZeneca devine prima terapie cu anticorpi autorizată în SUA pentru profilaxia pre-expunere a COVID-19]]></title>
            <description><![CDATA[Evusheld de la AstraZeneca devine prima terapie cu anticorpi autorizată în SUA pentru profilaxia pre-expunere a COVID-19]]></description>
            <link>https://sps.devopsroom.com/evusheld-de-la-astrazeneca-devine-prima-terapie-cu-anticorpi-autorizata-in-sua-pentru-profilaxia-pre-expunere-a-covid-19_2141760.html</link>
            <guid isPermaLink="true">https://sps.devopsroom.com/evusheld-de-la-astrazeneca-devine-prima-terapie-cu-anticorpi-autorizata-in-sua-pentru-profilaxia-pre-expunere-a-covid-19_2141760.html</guid>
                        <category><![CDATA[fda]]></category>
                        <category><![CDATA[EMA]]></category>
                        <category><![CDATA[SARS-CoV-2]]></category>
                        <category><![CDATA[anticorpi monoclonali]]></category>
                        <category><![CDATA[terapie cu anticorpi]]></category>
                        <category><![CDATA[Evusheld]]></category>
                        <category><![CDATA[Omicron]]></category>
                        <category><![CDATA[tixagevimab]]></category>
                        <category><![CDATA[cilgavimab]]></category>
                        <category><![CDATA[Emergency Use Authorization]]></category>
                        <category><![CDATA[Știrile Zilei]]></category>
                        <category><![CDATA[Sănătate]]></category>
                        <category><![CDATA[Instant Articles]]></category>
                        <category><![CDATA[Tarom AirFi]]></category>
                        <dc:creator><![CDATA[Denisa Miron, Colaborator]]></dc:creator>
            <pubDate>Mon, 13 Dec 2021 12:00:17 GMT</pubDate>
            <enclosure url="https://sps.devopsroom.com/media/images/202112/1600x900/media-163939669339114300.webp" length="0" type="image/webp"/>
        </item>
            </channel>
</rss>
